11.66
price up icon1.13%   0.13
after-market After Hours: 11.66
loading

Urogen Pharma Ltd Stock (URGN) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
20.18%
18.78
23.53 20.85 21.14 17.19
Cost Of Revenue
24.41%
1.728
2.286 2.367 2.443 2.265
Gross Profit
19.73%
17.05
21.24 18.48 18.70 14.93
Operating Expenses
19.36%
42.79
35.85 31.98 34.08 36.97
Benefits Costs and Expenses
11.65%
51.01
45.69 42.74 45.22 47.38
Costs And Expenses
11.65%
51.01
45.69 42.74 45.22 47.38
Operating Income/Loss
76.19%
-25.74
-14.61 -13.50 -15.38 -22.05
Nonoperating Income/Loss
122.54%
-0.183
0.812 0.071 -0.03 -0.015
Income/Loss From Continuing Operations Before Tax
45.44%
-32.23
-22.16 -21.89 -24.08 -30.19
Income Tax Expense/Benefit
98.60%
0.054
3.854 -0.009 0.054 0.021
Income/Loss From Continuing Operations After Tax
24.10%
-32.29
-26.02 -21.88 -24.14 -30.21
Net Income/Loss
24.10%
-32.29
-26.02 -21.88 -24.14 -30.21
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,248%
33.38
2.4756 32.30 23.46 23.28
Basic Earnings Per Share
46.97%
-0.97
-0.66 -0.68 -1.03 -1.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$78.94
price up icon 2.53%
$318.85
price up icon 1.51%
$33.41
price up icon 0.00%
$20.11
price up icon 1.41%
$99.27
price up icon 0.31%
biotechnology ONC
$266.26
price up icon 1.87%
Cap:     |  Volume (24h):